ADMP Stock Recent News

ADMP LATEST HEADLINES

ADMP Stock News Image - GlobeNewsWire

SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced that it will host an investor conference call on Wednesday, August 10, 2022 at 1:30 p.m. Pacific Time to discuss its financial and operating results for the second quarter 2022 as well as provide a corporate update. The company's press release concerning its second quarter 2022 financial results is expected to be available after 1 p.m. Pacific Time on August 10, 2022, and on its website .

GlobeNewsWire 2022 Aug 08
ADMP Stock News Image - PennyStocks

Are these tips part of your penny stocks trading strategy? The post What to Look For in a Penny Stock in 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PennyStocks 2022 Jul 31
ADMP Stock News Image - Zacks Investment Research

Adamis (ADMP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research 2022 May 31
ADMP Stock News Image - Seeking Alpha

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP ) Q1 2022 Earnings Conference Call May 16, 2022 5:00 PM ET Corporate Participants Robert Uhl - ICR Westwicke Dennis Carlo - President and Chief Executive Officer David Benedicto - Chief Financial Officer Ron Moss - Chief Medical Officer David Marguglio - Chief Business Officer Conference Call Participants Operator Good evening, and welcome to the Adamis Pharmaceuticals First Quarter 2022 Financial Results Conference Call. All participants will be in a listen-only mode.

Seeking Alpha 2022 May 16
ADMP Stock News Image - GlobeNewsWire

SAN DIEGO, May 09, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced that it will host an investor conference call on Monday, May 16, 2022 at 2 p.m. Pacific Time to discuss its financial and operating results for the first quarter 2022 as well as provide a business update. The company's press release concerning its first quarter 2022 financial results is expected to be available after 1 p.m. Pacific Time on May 16, 2022, and on its website.

GlobeNewsWire 2022 May 09
ADMP Stock News Image - Zacks Investment Research

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

Zacks Investment Research 2022 May 09
6 of 16